Clinical trial of CI-501 (Camolar) against cutaneous leishmaniasis in Ethiopia.
D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male
D000962:Antimalarials